↓ Skip to main content

Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer

Overview of attention for article published in European Journal of Clinical Pharmacology, June 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
patent
2 patents

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
67 Mendeley
Title
Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer
Published in
European Journal of Clinical Pharmacology, June 2013
DOI 10.1007/s00228-013-1546-0
Pubmed ID
Authors

Antonio Ruggiero, Silvia Triarico, Giovanna Trombatore, Andrea Battista, Fabiola Dell’Acqua, Carmelo Rizzari, Riccardo Riccardi

Abstract

Hypersensitivity reactions (HSRs) may occur in children with cancer during the use of almost all chemotherapeutic drugs. HSRs may also produce a negative impact on treatment intensity and, as a consequence, worsen patients' outcome. The aim of this review is to summarize the incidence and the clinical features of HSRs occurring in children with cancer treated with chemotherapeutic drugs and their impact on treatment efficacy, in order to outline possible adequate prevention and management strategies.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 3%
Spain 1 1%
Unknown 64 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 24%
Other 8 12%
Student > Ph. D. Student 6 9%
Student > Master 6 9%
Student > Postgraduate 4 6%
Other 12 18%
Unknown 15 22%
Readers by discipline Count As %
Medicine and Dentistry 29 43%
Biochemistry, Genetics and Molecular Biology 5 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Nursing and Health Professions 2 3%
Agricultural and Biological Sciences 2 3%
Other 5 7%
Unknown 20 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 October 2020.
All research outputs
#4,499,511
of 22,729,647 outputs
Outputs from European Journal of Clinical Pharmacology
#421
of 2,553 outputs
Outputs of similar age
#38,955
of 198,015 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#6
of 26 outputs
Altmetric has tracked 22,729,647 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,553 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,015 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.